NovoCure (NVCR) Interest Expenses (2014 - 2026)
NovoCure (NVCR) posted Interest Expenses of $5.5 million for Q2 2026, up 1.6% sequentially from $5.4 million in Q1 2026, and up 93.13% YoY from $2.8 million in Q2 2025.
NovoCure (NVCR) Interest Expenses (2014 - 2026) Analysis & Trends
NovoCure has reported Interest Expenses for 13 years, with the latest figure at $5.5 million in Q2 2026.
- Quarterly Interest Expenses rose 93.13% year-over-year to $5.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.6 million (up 64.36% YoY) and the FY2025 annual result came in at $1.8 billion, up 12.0% from the prior year.
- Interest Expenses grew to $5.5 million in Q2 2026 per NVCR's latest filing, from $5.4 million in the prior quarter.
- Over five years, Interest Expenses peaked at $5.5 million in Q2 2026 and troughed at -$2.4 million in Q4 2022.
- A 5-year average of $2.5 million and a median of $2.7 million in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses slumped 138.24% in 2022, then soared 139400.0% in 2025.
- Over 5 years, Interest Expenses stood at -$2.4 million in 2022, then surged by 302.69% to $4.9 million in 2023, then slumped by 47.71% to $2.6 million in 2024, then surged by 88.11% to $4.8 million in 2025, then increased by 13.08% to $5.5 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $5.5 million, $5.4 million, and $4.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 141.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 176.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 96.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 114.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -110.42 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 15.80 Mn |
| 10 | NovoCure | 2.07 Bn | 1.63 Bn | 142.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.46 Mn |
| Jun 30, 2026 | 5.46 Mn |
| Mar 31, 2026 | 5.37 Mn |
| Mar 31, 2026 | 5.37 Mn |
| Dec 31, 2025 | 4.83 Mn |
| Dec 31, 2025 | 4.83 Mn |
| Sep 30, 2025 | 2.97 Mn |
| Sep 30, 2025 | 2.97 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |